Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results.
Objective B-cell activating factor (BAFF) is essential for B-cell survival and innate immune activation, and its ...
Immunosenescence is the age-related decline and remodeling of the immune system, profoundly influencing susceptibility to ...
Oligonucleotide-based therapeutics represent a frontier in immunology, regenerative medicine, and oncology, offering unparalleled precision in modulating ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today ...
What the research is about When a virus enters the body, our body quickly detects it and begins to respond. This first ...
Company continues to evaluate strategic options to maximize shareholder value - WATERTOWN, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the "Company” o ...
From May 15–16, 2026, the 3rd International Symposium “Frontiers in Skin Immunity” will bring leading experts in dermatology and immunology to Heidelberg. Organized by the SFB Transregio 156 “The Skin ...
Researchers at The University of Texas MD Anderson Cancer Center have identified a key enzyme—RNase H2—that helps ...
Ocular infections and related inflammatory disorders are important causes of visual morbidity worldwide and may arise from viral, bacterial, fungal, and ...
People with hard-to-treat asthma often have to use medicines such as systemic steroids that broadly suppress the immune ...
Hypersialylation in tumor cells is a potent mechanism of tumor immune evasion, pushing cancer progression by suppressing both innate and adaptive antitumor immunity. Shanghai Henlius Biotech Inc. has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results